Insulin Pens, Syringes, Pumps And Injectors Market Value is Expected to Reach $22,553.3 Million by 2023 | TBRC Reports

Insulin Pens, Syringes, Pumps And Injectors Market - By Devices (Pens, Injectors And Pumps, Syringes), By End-User (Homecare, Hospitals And Others), By Expenditure (Private, Public Healthcare), And By Region, Opportunities And Strategies – Global Forecast To 2030 By The Business Research Company

The global insulin pens, syringes, pumps and injectors market reached a value of nearly $16,148.7 million in 2019, having grown at a compound annual growth rate (CAGR) of 7.42% since 2015, and is expected to grow at a CAGR of 8.71% to nearly $22,553.3 million by 2023.

The key drivers of the insulin pens, syringes, pumps and injectors market include:-
Rise In Diabetic Population:
Rising number of diabetic cases will continue to be a driver of this market during the forecast period. According to the International Diabetes Federation (IDF), the global diabetic population is expected to reach 642 million by 2040. Thus the need for diabetes care equipment is set to rise steadily during the forecast period. The diabetic population (aged 20-79 years) in India is expected to reach 134.4 million by 2020 According to a study published by Lancet Diabetes & Endocrinology journal, the amount of insulin needed to treat diabetes type 2 will rise by more than 20% globally over the next 12 years. , Rising diabetic population coupled with the expected increase in the amount of insulin needed will drive the market for insulin pens, syringes, pumps and injectors in the forecast period.

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-market

Insulin Pens, Syringes, Pumps And Injectors Market Segmentation:-
The insulin pens, syringes, pumps and injectors market is segmented by type of devices, by end-user and by geography.
By Type Of Devices- The insulin pens, syringes, pumps and injectors market can be segmented by type of devices
a) Pens
b) Injectors And Pumps
c) Syringes
The pens market can be segmented into disposable pens and reusable pens. The injectors and pumps market can be segmented into pumps and injectors and the pumps market is further segmented into tubed pumps and tubeless pumps.
The pens market was the largest segment of the insulin pens, syringes, pumps and injectors market, accounting for 47.7% of the total in 2019. Going forward, the fastest-growing segments in the insulin pens, syringes, pumps and injectors market will be injectors and pumps, where growth will be at CAGR of 8.2%.

By End-Use – The insulin pens, syringes, pumps and injectors market are segmented at global leveltype of end-user into
a) Homecare
b) Hospitals
c) Others

By Type Of Expenditure – The insulin pens, syringes, pumps and injectors market are segmented at country level type of expenditure into
a) Public Healthcare Expenditure
b) Public Healthcare Expenditure

Request For A Sample Copy Of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2461&type=smp

By Geography - The insulin pens, syringes, pumps and injectors market is segmented into
1.North America
2.Western Europe
3.Asia Pacific
4.Eastern Europe
5.South America
6.Middle East
7.Africa

Some of the major key players involved in the insulin pens, syringes, pumps and injectors market are
• Eli Lilly and Company
• Medtronic plc
• Becton, Dickinson and Company
• Novo Nordisk A/S
• Insulet Corporation

Place a DIRECT PURCHASE ORDER of entire 300+ pages report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2461

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.